GH Research Plc (GHRS)
22.12
+0.35
(+1.61%)
USD |
NASDAQ |
May 22, 16:00
22.08
-0.04
(-0.16%)
After-Hours: 20:00
GH Research Shareholders Equity (Quarterly) : 263.38M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | 278.85M |
| Atai Beckley, Inc. | 198.68M |
| Avadel Pharmaceuticals Plc | 98.22M |
| Jazz Pharmaceuticals Plc | 4.532B |
| Nektar Therapeutics | 576.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 275.27M |
| Total Liabilities (Quarterly) | 11.89M |
| Debt to Equity Ratio | 0.0016 |
| Current Ratio | 23.04 |
| Net Debt Paydown Yield | 0.00% |